(Q34244242)

31 July 2017

The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms (English)

1 reference

31 July 2017

17

Augusto Orlandi

1 reference

31 July 2017

Italia Falcone

8

0 references

Marianna Desideri

Marianna Desideri

5

0 references

Giovanni Sette

Giovanni Sette

9

0 references

Adriana Eramo

Adriana Eramo

4

0 references

Andrea Anichini

Andrea Anichini

11

0 references

James A. McCubrey

James A McCubrey

13

0 references

Donatella Del Bufalo

Donatella Del Bufalo

20

0 references

Ruggero De Maria

18

Ruggero De Maria

1 reference

31 July 2017

7

Daniela Passeri

1 reference

31 July 2017

Ludovica Ciuffreda

1

1 reference

31 July 2017

Cristina Di Sanza

2

1 reference

31 July 2017

Ursula Cesta Incani

3

1 reference

31 July 2017

Francesca Biagioni

6

1 reference

31 July 2017

Paola Bergamo

10

1 reference

31 July 2017

Kanaga Sabapathy

12

1 reference

31 July 2017

Maria Rosaria Ricciardi

14

1 reference

31 July 2017

Agostino Tafuri

15

1 reference

31 July 2017

Giovanni Blandino

16

1 reference

31 July 2017

Francesco Cognetti

19

1 reference

31 July 2017

Michele Milella

21

1 reference

31 July 2017

4 January 2012

1 reference

Journal of Molecular Medicine

31 July 2017

1 reference

31 July 2017

90

1 reference

31 July 2017

6

1 reference

31 July 2017

667-679

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-011-0844-1

31 July 2017

0 references

cites work

Cell signaling and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

BRAF mutation predicts sensitivity to MEK inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

c-Jun promotes cellular survival by suppression of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Rewired ERK-JNK signaling pathways in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Preclinical profile of antitumor activity of a novel hydrophilic camptothecin, ST1968.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Suppression of PTEN expression is essential for antiapoptosis and cellular transformation by oncogenic Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

UVB-induced ERK/AKT-dependent PTEN suppression promotes survival of epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

The selectivity of protein kinase inhibitors: a further update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

PI3K/PTEN signaling in angiogenesis and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

PTEN function: how normal cells control it and tumour cells lose it

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Pten dose dictates cancer progression in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

PTEN: new insights into its regulation and function in skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Deregulated Akt3 activity promotes development of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Modeling genomic diversity and tumor dependency in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-011-0844-1

The chromosome 10 monosomy common in human melanomas results from loss of two separate tumor suppressor loci

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22215152

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22215152

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00109-011-0844-1

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference